How Smartwatches Use AI to Screen for High Blood Pressure

Image for Detecting signs of hypertension using wearable sensors

After studying this material, you should be able to:

  1. Explain why hypertension is a critical public health problem
  2. Describe how the AI-PPG-ACC-HTN system works technically
  3. Interpret the clinical performance metrics (sensitivity, specificity, PPV)
  4. Evaluate the system's role within existing clinical workflows
  5. Understand the limitations and appropriate use cases of the technology

Step-by-Step Teaching Guide

STEP 1: Understanding the Problem (The "Why")

What is Hypertension?

Normal Blood Pressure:  < 120/80 mmHg
Elevated:               120-129 / < 80 mmHg
Hypertension Stage 1:   130-139 / 80-89 mmHg
Hypertension Stage 2:   ≥ 140 / ≥ 90 mmHg

Why Is It Called the "Silent Killer"?

FeatureExplanation
No obvious symptomsPeople feel fine while damage accumulates
Delayed diagnosisFound only during incidental screening
ConsequencesStroke, heart failure, kidney damage
ScaleAffects 1 billion+ people globally

The Awareness Gap Problem

People with hypertension
         │
         ▼
    ~50% unaware ◄─── This is the critical gap
         │
         ▼
No treatment → Organ damage over years

⚠️ Key Insight: The problem is NOT that we lack treatments — it's that people don't know they need them, especially adults aged 18–44


STEP 2: Current Screening Methods and Their Limitations

Existing Approaches

METHOD 1: Office Blood Pressure Measurement
┌─────────────────────────────────────────┐
│  ✅ Gold standard for initial screening  │
│  ❌ Episodic (only when you visit)       │
│  ❌ "White coat effect" can skew results │
└─────────────────────────────────────────┘

METHOD 2: 24-Hour Ambulatory BP Monitoring (ABPM)
┌─────────────────────────────────────────┐
│  ✅ TRUE clinical gold standard          │
│  ✅ Captures real-world BP patterns      │
│  ❌ Expensive, inconvenient              │
│  ❌ Not widely accessible                │
└─────────────────────────────────────────┘

METHOD 3: Existing Cuffless Wearables
┌─────────────────────────────────────────┐
│  ✅ Convenient, passive                  │
│  ❌ Require regular cuff calibration     │
│  ❌ Only track RELATIVE changes          │
│  ❌ Cannot identify absolute hypertension│
└─────────────────────────────────────────┘

🎯 The Gap: We need something passive, scalable, and calibration-free that can identify absolute hypertensive states


STEP 3: The Solution — AI-PPG-ACC-HTN System

What Sensors Does It Use?

Sensor 1: Photoplethysmography (PPG)

How it works:
┌──────────────────────────────────────────┐
│  LED light shines into skin              │
│         ↓                                │
│  Blood absorbs light differently         │
│  depending on pulse volume               │
│         ↓                                │
│  Sensor detects light reflection changes │
│         ↓                                │
│  Creates a waveform of your pulse        │
└──────────────────────────────────────────┘

What it reveals about BP:
• Pulse wave shape
• Arterial stiffness signals
• Vascular resistance patterns

Sensor 2: Accelerometer (ACC)

How it works:
┌──────────────────────────────────────────┐
│  Detects tiny physical movements         │
│         ↓                                │
│  Captures Ballistocardiogram (BCG)       │
│  = micro-movements caused by             │
│    heart pumping blood                   │
└──────────────────────────────────────────┘

What it reveals about BP:
• Mechanical cardiac function
• Force of blood ejection
• Complementary to PPG signals

💡 Why Both? PPG captures vascular signals; ACC captures mechanical cardiac signals. Together they provide richer information than either alone — hence "multimodal"


STEP 4: How the AI System Works (Technical Architecture)

The Two-Stage Machine Learning Approach

STAGE 1: FEATURE LEARNING (Self-Supervised)
═══════════════════════════════════════════

Raw Data Input:
492,347 hours of sensor data
from 2,109 participants
(NO medical labels needed)
         │
         ▼
┌─────────────────────────────────┐
│  1-D Deep Convolutional         │
│  Neural Network                 │
│                                 │
│  Analyzes 15-second windows     │
│  of PPG + ACC simultaneously    │
└─────────────────────────────────┘
         │
         ▼
Contrastive Learning Objective:
"Windows from the SAME person 
 → map CLOSE together in space"
"Windows from DIFFERENT people
 → map FAR apart in space"
         │
         ▼
Result: Rich physiological 
"embeddings" (feature vectors)
capturing vascular + cardiac patterns
STAGE 2: CLASSIFICATION
═══════════════════════════════════════════

Many 15-second embeddings per person
         │
         ▼
    Mean Aggregation
    (average across days)
    
    Purpose: "Wash out" noise from:
    • Sudden movements
    • Temperature changes  
    • Activity bursts
         │
         ▼
Person-Level Embedding
    +
User's Height
(proxy for arterial path length —
 taller person = longer arteries = 
 different pulse wave timing)
         │
         ▼
┌─────────────────────────────────┐
│  Regularized Logistic           │
│  Regression Classifier          │
└─────────────────────────────────┘
         │
         ▼
Hypertension Probability Score
(0 to 1)

Why Height Matters

Taller person:
Heart → Wrist = LONGER distance
                     │
                     ▼
Pulse wave takes LONGER to travel
                     │
                     ▼
Affects timing features in waveform
                     │
                     ▼
Height corrects for this variation

STEP 5: Understanding the Performance Metrics

Key Definitions First

True Positive (TP):   System says hypertensive → Actually hypertensive ✅
True Negative (TN):   System says normal → Actually normal ✅
False Positive (FP):  System says hypertensive → Actually normal ❌
False Negative (FN):  System says normal → Actually hypertensive ❌

The Three Key Metrics

SENSITIVITY = TP / (TP + FN)
"Of all people WHO HAVE hypertension,
 how many did we CATCH?"
→ High sensitivity = fewer missed cases

SPECIFICITY = TN / (TN + FP)  
"Of all people WITHOUT hypertension,
 how many did we correctly CLEAR?"
→ High specificity = fewer false alarms

PPV (Positive Predictive Value) = TP / (TP + FP)
"If the system flags someone,
 how likely are they ACTUALLY hypertensive?"
→ High PPV = trustworthy positive results

Performance Comparison Table

Use Case 1: Initial Screening

MethodSensitivitySpecificityPPV
AI Smartwatch65.8%90.0%80.6%
Office BP55.3%—77.8%

📊 Interpretation: The smartwatch catches MORE hypertensive people (65.8% vs 55.3%) with FEWER false alarms (PPV 80.6% vs 77.8%) compared to standard office screening

Use Case 2: Confirmatory Testing (N=48 with elevated initial BP)

MethodSensitivitySpecificityPPV
AI Smartwatch78.4%90.9%96.7%
Return Office Visit67.6%63.6%86.2%
Home Monitoring89.2%81.8%94.3%

📊 Interpretation:

  • Smartwatch outperforms return office visits on ALL metrics
  • Smartwatch is competitive with multi-day home monitoring
  • PPV of 96.7% means: if the smartwatch confirms hypertension, there's a 96.7% chance it's real

STEP 6: What the AI "Sees" — Waveform Interpretation

Key Waveform Features Analyzed

PPG WAVEFORM LANDMARKS:
─────────────────────────────────────────
  ons = pulse onset (start of heartbeat)
  sys = systolic peak (maximum pressure)
  dic = dicrotic notch (aortic valve closes)
  dia = diastolic peak (reflected wave)

In hypertension, you typically see:
• Higher amplitude systolic peak
• Earlier/more prominent dicrotic notch
• Stiffer waveform shape
• Altered timing between landmarks
BCG (Accelerometer) WAVEFORM LANDMARKS:
─────────────────────────────────────────
  H, I, J, K, L, M, N waves

These reflect the MECHANICAL FORCES
of blood being pumped through the body.
Hypertension alters these force patterns.
SECOND DERIVATIVE OF PPG:
─────────────────────────────────────────
  a, b, c, d, e waves

Amplifies subtle changes in waveform
shape that are invisible in raw signal.
Highly sensitive to arterial stiffness.

🔬 Key Finding: The AI learned these physiological differences automatically through contrastive learning — without being explicitly programmed to look for them


STEP 7: Clinical Workflow Integration

Where Does This Technology Fit?

CURRENT WORKFLOW:
─────────────────────────────────────────
Person feels fine
      │
      ▼ (years may pass)
Incidental office visit
      │
      ▼
BP measured → Hypertension detected
      │
      ▼
Treatment begins (often late)
PROPOSED WORKFLOW WITH SMARTWATCH:
─────────────────────────────────────────
Person wears smartwatch daily (passive)
      │
      ▼
AI continuously analyzes PPG + ACC
      │
      ▼
High hypertension probability detected
      │
      ▼
User prompted: "Consider seeing a doctor"
      │
      ▼
Office visit → Formal diagnosis
      │
      ▼
Treatment begins EARLIER

What This System Is and Is NOT

✅ IS:                          ❌ IS NOT:
─────────────────────────────────────────────
Passive screening tool          Diagnostic device
Opportunistic detection         Replacement for cuff
Scalable population tool        Standalone medical tool
Early warning system            Exact BP measurement
Complement to clinical care     Clinical decision maker

STEP 8: Study Design and Validation

Clinical Study Details

Study Type: Prospective, multi-center
Sites: 5 US locations
Participants: 196 diverse adults
Exclusions: Known cardiovascular disease,
            BP medications

Gold Standard Used: 24-hour ABPM
(the most rigorous clinical benchmark)

Why This Study Design Matters

Design ChoiceWhy It Matters
Multi-centerReduces site-specific bias
Diverse participantsImproves generalizability
ABPM as gold standardMost rigorous comparison possible
No medication usersClean signal, no confounders
Prospective designForward-looking, reduces selection bias

Summary: The Big Picture

PROBLEM:
1 billion+ people have hypertension
50%+ don't know it
→ Silent damage accumulates

EXISTING SOLUTIONS FALL SHORT:
Office visits: episodic, miss many cases
Cuffless wearables: need calibration

NEW SOLUTION (AI-PPG-ACC-HTN):
Uses PPG + ACC from consumer smartwatch
↓
Self-supervised AI learns physiological 
signatures of hypertension
↓
Aggregates signals over days (reduces noise)
↓
Outputs hypertension probability score
↓
Performance comparable to clinical workflows

IMPACT:
Passive, scalable, calibration-free screening
→ Prompts at-risk people to seek care
→ Earlier diagnosis
→ Reduced cardiovascular damage

Quick Self-Assessment Questions

  1. Why can't existing cuffless wearables independently screen for hypertension?
  2. What is the difference between sensitivity and PPV? Why does high PPV matter for confirmatory testing?
  3. Why does the system aggregate embeddings over multiple days rather than using a single reading?
  4. What role does height play in the classification model?
  5. In what scenario does the smartwatch system most outperform traditional methods?

💡 Answers: Review Steps 2, 5, 4, 3, and 5 respectively to verify your understanding

More to study